Mirum Pharmaceuticals, Inc.
MIRM
Rank in Stocks
#3278
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Share Price
$82.58
Last synced: 2026-10-19
Market Cap
$5.36B
Change (1 day)
3.05%
Change (1 year)
13.08%
Country
US
Trade Mirum Pharmaceuticals, Inc. (MIRM)
Category
Healthcare
Stock split history for Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. stock (symbol: MIRM) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One MIRM share bought prior to Oct 20, 2026 would equal to 0 MIRM shares today.
The most recent stock split occurred on Oct 20, 2026.
One MIRM share bought prior to Oct 20, 2026 would equal to 0 MIRM shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
